ID
45593
Description
Principal Investigator: Lisa Boardman, MD, Mayo Clinic, Rochester, MN, USA MeSH: Colorectal Neoplasms,Adenoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001384 In the US, CRC incidence has declined with uptake in colonoscopy for early detection and removal of polyps, the precursor lesion, can stop a cancer from developing but in spite of this, CRC remains the second leading cause of cancer death in the United States. One third of people who undergo screening colonoscopy will have adenomatous polyps, but less than 5% of the time are these polyps presumed to go on to develop into cancer. Why does one polyp develop into cancer while another one that looks very similar does not. In this proposal we will identify what molecular genetic changes in the genome, in the mRNA expression and genetic methylation patterns will distinguish a polyp that has already transformed into cancer from one that has not.
Lien
Mots-clés
Versions (1)
- 06/02/23 06/02/23 - Simon Heim
Détendeur de droits
Lisa Boardman, MD, Mayo Clinic, Rochester, MN, USA
Téléchargé le
6 febbraio 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001384 Time Lapse to Cancer-Defining the Transition from Polyp to Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject source, and affection status for polyp to cancer.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use and sample source.
- This subject phenotype table includes subjects' age, sex, and race.
- This sample attributes table includes body site where sample was collected, analyte type, histological type, tumor status, tumor stage, and sequencing center.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject source, and affection status for polyp to cancer.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use and sample source.
- This subject phenotype table includes subjects' age, sex, and race.
- This sample attributes table includes body site where sample was collected, analyte type, histological type, tumor status, tumor stage, and sequencing center.
C0680251 (UMLS CUI [1,2])
C0685938 (UMLS CUI [1,2])
C0032584 (UMLS CUI [1,3])
C0021390 (UMLS CUI [1,4])
C0543467 (UMLS CUI [1,5])
C0014245 (UMLS CUI [1,6])
C0205210 (UMLS CUI [1,7])
C0332147 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,3])
C0685938 (UMLS CUI [1,4])
C0032584 (UMLS CUI [1,5])
C0241889 (UMLS CUI [1,6])
C0024623 (UMLS CUI [1,7])
C0153425 (UMLS CUI [1,8])
C0238198 (UMLS CUI [1,9])
C0009402 (UMLS CUI [1,10])
C0021390 (UMLS CUI [1,11])
C0014245 (UMLS CUI [1,12])
C0014245 (UMLS CUI [1,2])
C4723751 (UMLS CUI [1,3])
C0685938 (UMLS CUI [1,4])
C0032584 (UMLS CUI [1,5])
C0205539 (UMLS CUI [1,6])
C0749059 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
C0021430 (UMLS CUI [1,2])
C0033167 (UMLS CUI [1,2])